Literature DB >> 19186037

Pullulan acetate nanoparticles prepared by solvent diffusion method for epirubicin chemotherapy.

Hui-zhu Zhang1, Fu-ping Gao, Ling-rong Liu, Xue-min Li, Zhi-min Zhou, Xin-du Yang, Qi-qing Zhang.   

Abstract

Pullulan acetate (PA) was synthesized by the reaction of pullulan with acetic anhydride in the presence of pyridine. PA was characterized by Fourier transform infrared (FT-IR) and proton nuclear magnetic resonance ((1)H NMR). A solvent diffusion method was employed in the current work to prepare PA nanoparticles. This technique had some advantages compared with other methods. The particle size increased from 185.7 nm to 423.0 nm with the degree of acetylation increasing from 2.71 to 3.0. Drug-loaded PA nanoparticles were prepared for controlled release of epirubicin (EPI). The drug entrapment and drug content increased with the degree substitution of PA increasing. EPI was released from the nanoparticles in a biphasic profile with a fast release rate in the first 10h followed by a slow release in vitro. A higher cytotoxicity against KB cells was found for EPI-loaded PA nanoparticles in comparison with free EPI. Confocal laser scanning microscopy (CLSM) observations indicate that EPI-loaded nanoparticles were internalized and released in the cytoplasmic compartment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19186037     DOI: 10.1016/j.colsurfb.2008.12.039

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  7 in total

1.  Polysialic acid-polyethylene glycol conjugate-modified liposomes as a targeted drug delivery system for epirubicin to enhance anticancer efficiency.

Authors:  Ting Zhang; Songlei Zhou; Ling Hu; Bo Peng; Yang Liu; Xiang Luo; Xinrong Liu; Yanzhi Song; Yihui Deng
Journal:  Drug Deliv Transl Res       Date:  2018-06       Impact factor: 4.617

2.  RGD Peptide-Pegylated PLLA Nanoparticles Containing Epirubicin Hydrochloride Exhibit Receptor-Dependent Tumor Trafficking In Vitro and In Vivo.

Authors:  Ping Huang; Jun Wu; Ximeng Li; Xiaozheng Liu; Yinghuan Li; Guohui Cui
Journal:  Pharm Res       Date:  2015-01-16       Impact factor: 4.200

3.  Bioconjugation of recombinant tissue plasminogen activator to magnetic nanocarriers for targeted thrombolysis.

Authors:  Hung-Wei Yang; Mu-Yi Hua; Kun-Ju Lin; Shiaw-Pyng Wey; Rung-Ywan Tsai; Siao-Yun Wu; Yi-Ching Lu; Hao-Li Liu; Tony Wu; Yunn-Hwa Ma
Journal:  Int J Nanomedicine       Date:  2012-10-01

4.  Bovine serum albumin nanoparticles as controlled release carrier for local drug delivery to the inner ear.

Authors:  Zhan Yu; Min Yu; Zhibao Zhang; Ge Hong; Qingqing Xiong
Journal:  Nanoscale Res Lett       Date:  2014-07-09       Impact factor: 4.703

5.  Doxorubicin-modified magnetic nanoparticles as a drug delivery system for magnetic resonance imaging-monitoring magnet-enhancing tumor chemotherapy.

Authors:  Po-Chin Liang; Yung-Chu Chen; Chi-Feng Chiang; Lein-Ray Mo; Shwu-Yuan Wei; Wen-Yuan Hsieh; Win-Li Lin
Journal:  Int J Nanomedicine       Date:  2016-05-12

Review 6.  Overviews on the cellular uptake mechanism of polysaccharide colloidal nanoparticles.

Authors:  Sara Salatin; Ahmad Yari Khosroushahi
Journal:  J Cell Mol Med       Date:  2017-02-28       Impact factor: 5.310

7.  Cellular uptake mechanism and intracellular fate of hydrophobically modified pullulan nanoparticles.

Authors:  Liqin Jiang; Xuemin Li; Lingrong Liu; Qiqing Zhang
Journal:  Int J Nanomedicine       Date:  2013-05-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.